Navigation Links
RayBiotech, Inc. Announces New Diagnostic Core Facility Partnering Program
Date:4/19/2012

NORCROSS, Ga., April 19, 2012 /PRNewswire/ -- RayBiotech, Inc. today announced that it has formally launched a partnering program for select diagnostic core facilities at academic and government research institutes in the United States and Canada.  Under the terms of the partnership program, core diagnostics facilities will be able to provide proprietary RayBiotech proteomic analysis services as a component of their current services offerings at no cost to the core facilities.  These services will be provided to select cores which emphasize biomarker and proteomic analysis to their affiliated researchers.  Services such as RayBiotech's Quantibody® characterization of biomarker expression will be emphasized, but all of RayBiotech's services portfolio will be available for pass-through to core clients, including ELISA and phosphorylation array testing.  The ultimate goal of this program will be to aid researchers in accelerating drug discovery, drug target validation and disease-related efforts with an emphasis on impacting cancer and other disease-specific research initiatives.  The program will be offered exclusively to cores in North America. 

Commenting on the new program, RayBiotech's President, COO and Co-founder, Rani Huang, said, "Since the founding of RayBiotech over ten years ago we have had numerous longstanding and productive relationships with academic and governmental research institutes.  This is our effort to give back to these partners and to establish new relationships with cutting-edge cores willing to adapt our platforms into their diagnostic services programs."

About RayBiotech, Inc.

RayBiotech (www.raybiotech.com) pioneered the development of antibody and protein array technologies and provides reliable high-throughput platforms for identifying disease mechanisms, screening and validation of novel biomarkers and identification of new drug targets.  In 2001 RayBiotech introduced the first commercially available cytokine antibody array. Since then, RayBiotech array products have been featured in hundreds of publications, including some in top-tier journals: Nature, Nature Medicine, Cell, Lancet, PNAS (USA), and many others. Offering more antibody array choices than any of its competitors, RayBiotech has established a leading reputation for the high quality and innovative developments provided to the research community. RayBiotech continues to lead in the development of protein array technologies and is focused on further meeting the needs of clients in translating new knowledge of human biology to improved health. A spin-off from Emory University's School of Medicine, RayBiotech is privately owned, with headquarters in metropolitan Atlanta (Norcross, GA).

For More Information:

Rob Burgess, PhD
Director, Business Development
RayBiotech, Inc.
Phone: 770-729-2992
Email: rob@raybiotech.com


'/>"/>
SOURCE RayBiotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medivir Announces TMC435 in an Expanded Clinical Collaboration
2. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
3. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
4. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
5. Custom Spine Announces 510K Clearance for Securis Cannulated Screw System
6. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
7. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
8. ADVENTRX Announces Establishment of Regulatory Advisory Board
9. Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
10. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
11. GenVec Announces Research on Improved Vaccine Vectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... At its ... Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has ... was a member of the winning team for the 2015 Breakthrough Prize in Fundamental ...
(Date:10/9/2017)... Antonio, Texas (PRWEB) , ... ... ... new study published on October 5, 2017, in the medical journal, Epilepsia, ... equivalence with the gold standard, video EEG, in detecting generalized tonic-clonic seizures ...
(Date:10/7/2017)... ... October 06, 2017 , ... Phase ... metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers can ... Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ProxiMeta ...
(Date:10/6/2017)... , ... October 06, 2017 , ... ... within the healthcare and technology sector at their fourth annual Conference where founders, ... 30 inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
(Date:3/24/2017)... -- The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative high ... ... Maldives Immigration Controller ... (small picture on the right) have received the IAIR award for the ...
Breaking Biology News(10 mins):